SUBCLINICAL ATHEROSCLEROSIS EVOLUTION IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH ANTI-TNF ALPHA: 5 YEARS FOLLOW UP

被引:0
|
作者
Ortolan, A. [1 ]
Puato, M. [2 ]
Boschetti, G. [2 ]
Lorenzin, M. [1 ]
Hoxha, A. [1 ]
Punzi, L. [1 ]
Ramonda, R. [1 ]
机构
[1] Univ Padua, Dept Med DIMED, Rheumatol Unit, Padua, Italy
[2] Univ Padua, Dept Med DIMED, Clin Med 3, Padua, Italy
关键词
D O I
10.1136/annrheumdis-2017-eular.5545
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0745
引用
收藏
页码:1315 / 1316
页数:2
相关论文
共 50 条
  • [41] A favourable bone remodeling profile occurs early in patients with rheumatoid arthritis and psoriatic arthritis treated with Anti-TNFα therapy.
    Gibbs, Adrian
    Murray, Barbara
    Radovits, Bea
    Bresnihan, Barry
    Veale, Douglas
    McKenna, Malachi
    FitzGerald, Oliver
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S80 - S81
  • [42] INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH RITUXIMAB AND ANTI-TNF INHIBITOR
    Zehraoui, N.
    Boutaleb, R. Benaziez.
    Hafirassou, H.
    Mechid, F.
    Bahaz, N.
    Makhloufi-Dahou, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1144 - 1144
  • [43] Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNF alpha therapy
    Marotte, Hubert
    Miossec, Pierre
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 663 - 669
  • [44] Visual evoked potentials (VEPS) in patients with rheumatoid arthritis treated with anti-TNF alpha antagonist infliximab
    Kotyla, PJ
    Lewicki, M
    Bal, A
    Sliwinska-Kotyla, B
    Kotulska, AT
    Kucharz, EJ
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 420 - 420
  • [45] Immune cell activity during anti-TNF treatment in patients with psoriasis and psoriatic arthritis
    Petrovic, Aleksandra
    Samuelsen, Victoria Marie
    Davies, Richard
    Aarebrot, Anders Krogh
    Holmes, Tim
    Sarkar, Irene
    Bergum, Brith
    Jonsson, Roland
    Sandvik, Lene Froyen
    Solberg, Silje Michelsen
    Appel, Silke
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 858 - 858
  • [46] Immune cell activity during anti-TNF treatment in patients with psoriasis and psoriatic arthritis
    Petrovic, Aleksandra
    Samuelsen, Victoria Marie
    Davies, Richard
    Aarebrot, Anders K.
    Holmes, Timothy
    Sarkar, Irene
    Bergum, Brith
    Jonsson, Roland
    Sandvik, Lene F.
    Solberg, Silje M.
    Appel, Silke
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2024, 218 (03): : 329 - 340
  • [47] Profile of Joint Involvement over Time in Rheumatoid Arthritis and Psoriatic Arthritis Patients Treated with Anti-TNF in a Real-World Setting
    Jovaisas, Algis
    Starr, Michael
    Choquette, Denis
    Zummer, Michel
    Arendse, Regan
    Sholter, Dalton
    Faraawi, Rafat
    Rodrigues, Jude
    Rampakakis, Emmanouil
    Sampalis, John S.
    Nantel, Francois
    Lehman, Allen J.
    Otawa, Susan
    Shawi, May
    Maslova, Karina
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [48] PROFILE OF JOINT INVOLVEMENT OVER TIME IN RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS TREATED WITH ANTI-TNF IN A REAL-WORLD SETTING
    Jovaisas, A.
    Starr, M.
    Choquette, D.
    Zummer, M.
    Arendse, R.
    Sholter, D.
    Faraawi, R.
    Rodrigues, J.
    Kapur, S.
    Rampakakis, E.
    Sampalis, J. S.
    Nantel, F.
    Lehman, A.
    Otawa, S.
    Shawi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 904 - 905
  • [49] PERSISTENCY WITH SUBCUTANEOUS ANTI-TNF THERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS PATIENTS
    Tandon, N.
    Haas, S.
    Waters, H.
    Olson, W.
    Bolge, S.
    Gunnarsson, C.
    VALUE IN HEALTH, 2012, 15 (04) : A41 - A41
  • [50] EVOLUTION OF ASDAS AND BASDAI IN PATIENTS WITH SPONDYLOARTHRITIS TREATED WITH ANTI-TNF ALFA
    Fonsalia, V.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S114 - S115